Related Experiment Video
Updated: May 11, 2026

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
Published on: December 6, 2016
Structural and vascular alterations of deep cervical lymph nodes in amyloid PET-positive Alzheimer's disease patients
Tae Hyung Kim1, Jin Geun Kwon1, Jimmy Sung-Chuan Chao1
1Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Background:
Impaired clearance of brain-derived waste via the glymphatic-lymphatic system has been implicated in Alzheimer's disease (AD) pathogenesis. Although animal studies highlight the role of deep cervical lymph nodes (dCLNs) in draining brain interstitial solutes, their characteristics in AD patients remain unknown. This study assessed structural and vascular alterations of dCLNs in AD using high-frequency color Doppler ultrasound (HFCDU).
Methods:
Twenty-five patients with amyloid PET-positive AD and 25 age-matched cognitively normal controls underwent HFCDU of dCLNs at neck zone 2-5. Lymph node number, shape, morphology, vascularity (via Superb Microvascular Imaging, SMI), and Solbiati index were quantified. Between-group differences were analyzed using logistic regression and receiver operating characteristic (ROC) analyses, and a simplified diagnostic score was developed from discriminative features.
Results:
A total of 482 lymph nodes were analyzed (210 from AD, 272 from controls). AD patients had fewer oval-shaped nodes (50% vs. 83%, p<0.001), more irregular morphology (23% vs. 1%, p<0.001), and less distinct internal structure (40% vs. 57%, p<0.001). In Zone 5, they also had fewer nodes (2.4 ± 1.8 vs. 3.8 ± 2.6, p=0.034) and reduced SMI positivity (75% vs. 91%, p=0.006). The count of oval, moderately vascularized (SMI ≤7) nodes in Zone 5 best discriminated AD (AUC=0.79). A composite score integrating these parameters yielded AUC=0.81 (sensitivity 64%, specificity 84%).
Conclusions:
HFCDU demonstrated distinct morphological and vascular abnormalities of dCLNs in AD, particularly in Zone 5, suggesting impaired lymphatic drainage contributes to AD pathology and supporting lymphatic imaging as a potential biomarker for the failure of lymphatic drainage of the brain.
More Related Videos
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction